Published in Intensive Care Med on January 01, 1993
Clearance of atracurium and laudanosine in the urine and by continuous venovenous haemofiltration. Br J Anaesth (1991) 1.48
Sedation in intensive care--a postal survey. Intensive Care Med (1987) 1.26
Cardiovascular and neurological effects of laudanosine. Studies in mice and rats, and in conscious and anaesthetized dogs. Br J Anaesth (1987) 0.93
Sedation for ventilation. A retrospective study of fifty patients. Anaesthesia (1980) 0.91
Pharmacokinetics of atracurium in acute hepatic failure (with acute renal failure). Br J Anaesth (1983) 0.87
Concentrations of atracurium and laudanosine in cerebrospinal fluid and plasma in three intensive care patients. Br J Anaesth (1990) 0.86
The pharmacokinetics and pharmacodynamics of atracurium in patients with and without renal failure. Anesthesiology (1984) 0.85
Atracurium infusions in patients with renal failure on an ITU. Anaesthesia (1986) 0.84
Clinical experience and plasma laudanosine concentrations during the infusion of atracurium in the intensive therapy unit. Br J Anaesth (1987) 0.84
Determination of atracurium, laudanosine and related compounds in plasma by high-performance liquid chromatography. J Chromatogr (1985) 0.82
Bupivacaine versus bupivacaine plus fentanyl for epidural analgesia: effect on maternal satisfaction. BMJ (1991) 2.21
Examination of some factors responsible for a food-induced increase in absorption of atovaquone. Br J Clin Pharmacol (1994) 1.63
Bgp2, a new member of the carcinoembryonic antigen-related gene family, encodes an alternative receptor for mouse hepatitis viruses. J Virol (1994) 1.58
The interaction between propranolol and the novel antimigraine agent zolmitriptan (311C90). Br J Clin Pharmacol (1997) 1.52
Characterization of bovine herpesvirus 1 UL49 homolog gene and product: bovine herpesvirus 1 UL49 homolog is dispensable for virus growth. J Virol (1995) 1.48
Association of biliary glycoprotein with protein tyrosine phosphatase SHP-1 in malignant colon epithelial cells. Oncogene (1997) 1.25
Arachidonic acid 15-lipoxygenase from rabbit peritoneal polymorphonuclear leukocytes. Partial purification and properties. J Biol Chem (1981) 1.25
Pharmacokinetics, pharmacodynamics and dose-response relationships of atracurium administered i.v. Br J Anaesth (1983) 1.23
Sodium valproate acutely inhibits lamotrigine metabolism. Br J Clin Pharmacol (1992) 1.18
Pediatric psychotropic medication compliance: a literature review and research-based suggestions for improving treatment compliance. J Child Adolesc Psychopharmacol (2001) 1.18
Bovine herpesvirus 1 UL49.5 homolog gene encodes a novel viral envelope protein that forms a disulfide-linked complex with a second virion structural protein. J Virol (1996) 1.16
Study of immunogenicity and virulence of bovine herpesvirus 1 mutants deficient in the UL49 homolog, UL49.5 homolog and dUTPase genes in cattle. Vaccine (1997) 1.12
The pharmacokinetics, tolerability and pharmacodynamics of tucaresol (589C80; 4[2-formyl-3-hydroxyphenoxymethyl] benzoic acid), a potential anti-sickling agent, following oral administration to healthy subjects. Br J Clin Pharmacol (1993) 1.02
Comparative disposition of codeine and pholcodine in man after single oral doses. Br J Clin Pharmacol (1986) 0.94
Relationship between BMI, physical fitness, and motor skills in youth with mild intellectual disabilities. Int J Obes (Lond) (2006) 0.93
The effects in volunteers of BW12C, a compound designed to left-shift the blood-oxygen saturation curve. Br J Clin Pharmacol (1985) 0.92
Determination of 1-diethylcarbamoyl-4-methylpiperazine (diethylcarbamazine) in human plasma and urine. J Chromatogr (1979) 0.92
Epidural fentanyl and 0.5% bupivacaine for elective caesarean section. Anaesthesia (1990) 0.87
Anaesthetic clinical indicators in public hospitals providing anaesthetic care in Hong Kong: prospective study. Hong Kong Med J (2001) 0.84
Determination of 2,4-diamino-5-(3,4-dichlorophenyl)-6-methylpyrimidine (BW 197U) in human plasma. J Chromatogr (1977) 0.84
Effect of sevoflurane/nitrous oxide versus propofol anaesthesia on somatosensory evoked potential monitoring of the spinal cord during surgery to correct scoliosis. Br J Anaesth (2002) 0.83
Electrogastrographic changes in children who undergo day-surgery anesthesia. J Pediatr Surg (1999) 0.83
Carbamazepine and lamotrigine in healthy volunteers: relevance to early tolerance and clinical trial dosage. Epilepsia (1993) 0.83
Acute pain services in Hong Kong: facilities, volume, and quality. Hong Kong Med J (2002) 0.82
Plasma levels of diethylcarbamazine in man. Trans R Soc Trop Med Hyg (1977) 0.82
Pharmacokinetics of atracurium and its metabolites in patients with normal renal function, and in patients in renal failure. Br J Anaesth (1987) 0.81
The influence of intrathecal fentanyl on the characteristics of subarachnoid block for caesarean section. Anaesthesia (1998) 0.80
Pharmacokinetics of atracurium besylate in healthy patients (after a single i.v. bolus dose). Br J Anaesth (1983) 0.80
Role of stored iron in atherosclerosis. J Vasc Nurs (2000) 0.79
The pharmacodynamics and pharmacokinetics of the 5HT1B/1D-agonist zolmitriptan in healthy young and elderly men and women. Clin Pharmacol Ther (1998) 0.79
Sound-induced frive, prior motion restraint, and reduced sensory stimulation effects on rocking behavior in retarded persons. Am J Ment Defic (1975) 0.78
The iron (Fe) and atherosclerosis study (FeAST): a pilot study of reduction of body iron stores in atherosclerotic peripheral vascular disease. Am Heart J (2000) 0.78
Relationship of growth hormone to the growth retardation associated with maternal dietary restriction. J Nutr (1971) 0.77
Forecasting the antimalarial activities of arylamidinoureas from their measured physicochemical properties. Br J Pharmacol (1975) 0.75
Pharmacokinetics and tolerability of single oral doses of 882C87, a potent, new anti-varicella-zoster virus agent, in healthy volunteers. Antimicrob Agents Chemother (1995) 0.75
Treatment of CMV retinitis with intravitral ganciclovir in the HAART era. Can J Infect Dis (2001) 0.75
Lack of interaction between valaciclovir, the L-valyl ester of aciclovir, and digoxin. Br J Clin Pharmacol (1998) 0.75
Pharmacokinetics of atracurium and its metabolites. Br J Anaesth (1986) 0.75
Strengthening of porcelain by ion exchange subsequent to thermal tempering. Dent Mater (1992) 0.75
Risks posed by the use of oxygen therapy and non-invasive positive pressure ventilation: a pilot study. Hong Kong Med J (2009) 0.75
SNAREdinburgh: the molecular mechanisms of exocytosis and endocytosis. Trends Neurosci (2001) 0.75
The pharmacokinetics of recombinant double-chain t-PA (duteplase): effects of bolus injection, infusions, and administration by weight in patients with myocardial infarction. Clin Pharmacol Ther (1991) 0.75
Multiple dose pharmacokinetics of intravenous acyclovir in patients on continuous ambulatory peritoneal dialysis. J Antimicrob Chemother (1987) 0.75
The use of gas-liquid chromatography-mass spectrometry in biochemical pharmacology. Br J Pharmacol (1970) 0.75
Five cases of severe cardiac disease in pregnancy: outcomes and costs. Int J Obstet Anesth (2001) 0.75
Introducing an acute pain service. Br J Hosp Med (1996) 0.75
Pharmacokinetics and dynamics of atracurium infusions after paediatric orthotopic liver transplantation. Br J Anaesth (2000) 0.75
The curve through the expected values of ordered variates and the sum of squares of normal scores. Biometrika (1966) 0.75
Pituitary adenylate cyclase-activating polypeptide and its receptors in amphibians. Microsc Res Tech (2001) 0.75